Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness and safety of three dosing regimens of paliperidone palmitate in adults with schizophrenia has completed. The update …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone palmitate (Paliperidone palmitate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED